Anavex Life Sciences Corp (AVXL)

[Investor2014]

I was thinking about this interview with Missling (from SEC filing):

TWST: I know you are knee-deep in some very important work, but if, let us say all goes well, where do you see the company going in the future? Do you want to stay in the neurology area? Do you see increased partnerships in the future? Can you elaborate on any kind of longer-term vision?

Dr. Missling: Yes, we are focusing on the central nervous system. And I mentioned specifically indications like Alzheimer’s and Parkinson’s disease, and then also for the neurodevelopmental orphan designations or rare diseases like Rett syndrome, infantile spasm and Fragile X, which is a special form of autism. Then, we also work on improving pain management. So we have a balanced pipeline, but the main focus is indeed on the central nervous system.

TWST: Did you want to say anything further on partnerships?

Dr. Missling: For larger markets like Alzheimer’s disease, partnerships for commercialization are very common. This is something that no small company can market by itself and, for that reason, at some point in time, there will be certainly discussions in that direction.

TWST: When might that be happening? Perhaps pre-Phase 3 or afterwards?

Dr. Missling: Our goal is always to create the highest possible value for shareholders. When you enter into such a collaboration or partnership for a larger indication, we will always try to aim for improving the outcome for the shareholders.

Admittedly it does not preclude partnership for P2/3, but held together with above and Missling having repeatedly stated that Anavex have enough cash for 2 years, I interpret that to mean partnership is most likeby for the commercialisation stage - hoping that we in fact get that far...